Predictive Value of Plasma NGAL:Hepcidin-25 for Major Adverse Kidney Events After Cardiac Surgery with Cardiopulmonary Bypass: A Pilot Study
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Neutrophil gelatinase-associated lipocalin (NGAL) and hepcidin-25 are involved in catalytic iron-related kidney injury after cardiac surgery with cardiopulmonary bypass. We explored the predictive value of plasma NGAL, plasma hepcidin-25, and the plasma NGAL:hepcidin-25 ratio for major adverse kidney events (MAKE) after cardiac surgery. Methods: We compared the predictive value of plasma NGAL, hepcidin-25, and plasma NGAL:hepcidin-25 with that of serum creatinine (Cr) and urinary output and protein for primary-endpoint MAKE (acute kidney injury [AKI] stages 2 and 3, persistent AKI >48 hours, acute dialysis, and in-hospital mortality) and secondary-endpoint AKI in 100 cardiac surgery patients at intensive care unit (ICU) admission. We performed ROC curve, logistic regression, and reclassification analyses. Results: At ICU admission, plasma NGAL, plasma NGAL:hepcidin-25, plasma interleukin-6, and Cr predicted MAKE (area under the ROC curve [AUC]: 0.77, 0.79, 0.74, and 0.74, respectively) and AKI (0.73, 0.89, 0.70, and 0.69). For AKI prediction, plasma NGAL:hepcidin-25 had a higher discriminatory power than Cr (AUC difference 0.26 [95% CI 0.00–0.53]). Urinary output and protein, plasma lactate, C-reactive protein, creatine kinase myocardial band, and brain natriuretic peptide did not predict MAKE or AKI (AUC <0.70). Only plasma NGAL:hepcidin-25 correctly reclassified patients according to their MAKE and AKI status (category-free net reclassification improvement: 0.82 [95% CI 0.12–1.52], 1.03 [0.29–1.77]). After adjustment to the Cleveland risk score, plasma NGAL:hepcidin-25 ≥0.9 independently predicted MAKE (adjusted odds ratio 16.34 [95% CI 1.77–150.49], P=0.014). Conclusions: Plasma NGAL:hepcidin-25 is a promising marker for predicting postoperative MAKE.
Abstract
Background: Neutrophil gelatinase-associated lipocalin (NGAL) and hepcidin-25 are involved in catalytic iron-related kidney injury after cardiac surgery with cardiopulmonary bypass. We explored the predictive value of plasma NGAL, plasma hepcidin-25, and the plasma NGAL:hepcidin-25 ratio for major adverse kidney events (MAKE) after cardiac surgery. Methods: We compared the predictive value of plasma NGAL, hepcidin-25, and plasma NGAL:hepcidin-25 with that of serum creatinine (Cr) and urinary output and protein for primary-endpoint MAKE (acute kidney injury [AKI] stages 2 and 3, persistent AKI >48 hours, acute dialysis, and in-hospital mortality) and secondary-endpoint AKI in 100 cardiac surgery patients at intensive care unit (ICU) admission. We performed ROC curve, logistic regression, and reclassification analyses. Results: At ICU admission, plasma NGAL, plasma NGAL:hepcidin-25, plasma interleukin-6, and Cr predicted MAKE (area under the ROC curve [AUC]: 0.77, 0.79, 0.74, and 0.74, respectively) and AKI (0.73, 0.89, 0.70, and 0.69). For AKI prediction, plasma NGAL:hepcidin-25 had a higher discriminatory power than Cr (AUC difference 0.26 [95% CI 0.00–0.53]). Urinary output and protein, plasma lactate, C-reactive protein, creatine kinase myocardial band, and brain natriuretic peptide did not predict MAKE or AKI (AUC <0.70). Only plasma NGAL:hepcidin-25 correctly reclassified patients according to their MAKE and AKI status (category-free net reclassification improvement: 0.82 [95% CI 0.12–1.52], 1.03 [0.29–1.77]). After adjustment to the Cleveland risk score, plasma NGAL:hepcidin-25 ≥0.9 independently predicted MAKE (adjusted odds ratio 16.34 [95% CI 1.77–150.49], P=0.014). Conclusions: Plasma NGAL:hepcidin-25 is a promising marker for predicting postoperative MAKE.
참고문헌 (40)
- Thiele RH, "AKI associated with cardiac surgery", Clin J Am Soc Nephrol, 10, pp.500~514 (2015)
- Kellum JA, "Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for Acute Kidney Injury", Kidney Int Suppl, 2, pp.1~138 (2012)
- Thakar CV, "A clinical score to predict acute renal failure after cardiac surgery", J Am Soc Nephrol, 16, pp.162~168 (2005)
- McCullough PA, "Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference", Contrib Nephrol, 182, pp.13~29 (2013)
- Haase M, "Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury", J Am Coll Cardiol, 55, pp.2024~2033 (2010)
- Leaf DE, "Iron, hepcidin, and death in human AKI", J Am Soc Nephrol, 30, pp.493~504 (2019)
- Balla G, "Ferritin: a cytoprotective antioxidant strategem of endothelium", J Biol Chem, 267, pp.18148~18153 (1992)
- Mori K, "Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury", J Clin Invest, 115, pp.610~621 (2005)
- Gueret G, "Acute renal dysfunction after cardiac surgery with cardiopulmonary bypass is associated with plasmatic IL6 increase", Cytokine, 45, pp.92~98 (2009)
- Hur M, "Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis", BMC Infect Dis, 14, pp.224~ (2014)
- O’Neal JB, "Acute kidney injury following cardiac surgery: current understanding and future directions", Crit Care, 20, pp.187~ (2016)
- Hajjar LA, "High lactate levels are predictors of major complications after cardiac surgery", J Thorac Cardiovasc Surg, 146, pp.455~460 (2013)
- Albert C, "Neutrophil gelatinase-associated lipocalin measured on clinical laboratory platforms for the prediction of acute kidney injury and the associated need for dialysis therapy: A systematic review and meta-analysis", Am J Kidney Dis, 76, pp.826~841 (2020)
- von Elm E, "The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies", Int J Surg, 12, pp.1495~1499 (2014)
- Haase M, "Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: A multicenter double-blinded randomized controlled trial", PLoS Med, 10, pp.e1001426~ (2013)
- Christian Albert, "Urinary Biomarkers may Complement the Cleveland Score for Prediction of Adverse Kidney Events After Cardiac Surgery: A Pilot Study", Annals of Laboratory Medicine, 40(2), pp.131~141 (2020), 대한진단검사의학회[DOI]
- Bellomo R, "Acute Dialysis Quality Initiative workgroup. Acute renal failure–definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group", Crit Care, 8, pp.R204~R212 (2004)
- Englberger L, "Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery", Crit Care, 15, pp.R16~ (2011)
- Park CM, "Usefulness of plasma neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury after cardiopulmonary bypass in Korean cardiac patients: a prospective observational study", Clin Biochem, 48, pp.44~49 (2015)
- Tuladhar SM, "Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass", J Cardiovasc Pharmacol, 53, pp.261~266 (2009)
- Kerr KF, "Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers", Clin J Am Soc Nephrol, 9, pp.1488~1496 (2014)
- Mandrekar JN, "Receiver operating characteristic curve in diagnostic test assessment", J Thorac Oncol, 5, pp.1315~1316 (2010)
- Hanley JA, "A method of comparing the areas under receiver operating characteristic curves derived from the same cases", Radiology, 148, pp.839~843 (1983)
- Pencina MJ, "Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers", Stat Med, 30, pp.11~21 (2011)
- Vanmassenhove J, "Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature", Nephrol Dial Transplant, 28, pp.254~273 (2010)
- Donadio C, "Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients", Crit Care, 18, pp.R39~ (2014)
- 김한아, "Proenkephalin, Neutrophil Gelatinase-Associated Lipocalin, and Estimated Glomerular Filtration Rates in Patients With Sepsis", Annals of Laboratory Medicine, 37(5), pp.388~397 (2017), 대한진단검사의학회
- Mikłaszewska M, "Serum interleukin 6 levels as an early marker of acute kidney injury on children after cardiac surgery", Adv Clin Exp Med, 22, pp.377~386 (2013)
- Choi N, "Urinary hepcidin-25 is elevated in patients that avoid acute kidney injury following cardiac surgery", Can J Kidney Health Dis, 5, pp.2054358117~ (2018)
- Yi Ahram, "Effectiveness of Plasma and Urine Neutrophil Gelatinase-Associated Lipocalin for Predicting Acute Kidney Injury in High-Risk Patients", Annals of Laboratory Medicine, 41(1), pp.60~67 (2021), 대한진단검사의학회[DOI]
- Prowle JR, "Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass", Nephrol Dial Transplant, 27, pp.595~602 (2012)
- Choi N, "Early intraoperative iron-binding proteins are associated with acute kidney injury after cardiac surgery", J Thorac Cardiovasc Surg, 157, pp.287~297 (2019)
- van Swelm RPL, "Renal handling of circulating and renal-synthesized hepcidin and its protective effects against hemoglobin-mediated kidney injury", J Am Soc Nephrol, 27, pp.2720~2732 (2016)
- Swaminathan S, "Iron homeostasis pathways as therapeutic targets in acute kidney injury", Nephron, 140, pp.156~159 (2018)
- Mårtensson J, "Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients", Minerva Anestesiol, 81, pp.1192~1200 (2015)
- Ostermann M, "Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference", Kidney Int, 98, pp.294~309 (2020)
- Albert Christian, "Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?", Annals of Laboratory Medicine, 41(1), pp.1~15 (2021), 대한진단검사의학회[DOI]
- Haase-Fielitz A, "The effects of intensive versus routine treatment in patients with acute kidney injury", Dtsch Arztebl Int, 117, pp.289~296 (2020)
- Göcze I, "Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study", Ann Surg, 267, pp.1013~1020 (2018)
- Meersch M, "Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial", Intensive Care Med, 43, pp.1551~1561 (2017)